Get started
Author

Soichiro Matsushima

Involvement of BCRP (ABCG2) in the Biliary Excretion of Pitavastatin
2005 · Masaru Hirano, Kazuya Maeda, et al. · Molecular Pharmacology · 255
Identification of the Hepatic Efflux Transporters of Organic Anions Using Double-Transfected Madin-Darby Canine Kidney II Cells Expressing Human Organic Anion-Transporting Polypeptide 1B1 (OATP1B1)/Multidrug Resistance-Associated Protein 2, OATP1B1/Multidrug Resistance 1, and OATP1B1/Breast Cancer Resistance Protein
2005 · Soichiro Matsushima, Kazuya Maeda, et al. · Journal of Pharmacology and Experimental Therapeutics · 190
The Inhibition of Human Multidrug and Toxin Extrusion 1 Is Involved in the Drug-Drug Interaction Caused by Cimetidine
2008 · Soichiro Matsushima, Kazuya Maeda, et al. · Drug Metabolism and Disposition · 103
Involvement of Multiple Efflux Transporters in Hepatic Disposition of Fexofenadine
2008 · Soichiro Matsushima, Kazuya Maeda, et al. · Molecular Pharmacology · 93
Investigation of the Inhibitory Effects of Various Drugs on the Hepatic Uptake of Fexofenadine in Humans
2008 · Soichiro Matsushima, Kazuya Maeda, et al. · Drug Metabolism and Disposition · 88
Establishment of a Set of Double Transfectants Coexpressing Organic Anion Transporting Polypeptide 1B3 and Hepatic Efflux Transporters for the Characterization of the Hepatobiliary Transport of Telmisartan Acylglucuronide
2008 · Naoki Ishiguro, Kazuya Maeda, et al. · Drug Metabolism and Disposition · 81
Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria
2017 · Michihiro Hide, Hae-Sim Park, et al. · Journal of Dermatological Science · 71
PDF
Ethnic sensitivity assessment – pharmacokinetic comparability between Japanese and non-Japanese healthy subjects on selected mAbs
2014 · Soichiro Matsushima, Yue Huang, et al. · Expert Opinion on Drug Metabolism & Toxicology · 30
Efficacy and safety of omalizumab for the treatment of refractory chronic spontaneous urticaria in Japanese patients: Subgroup analysis of the phase 3 POLARIS study
2017 · Michihiro Hide, Atsuyuki Igarashi, et al. · Allergology International · 21
PDF
Efficacy, Safety and Pharmacokinetics of Indacaterol in Caucasian and Japanese Patients with Chronic Obstructive Pulmonary Disease
2010 · Motoi Hosoe, Ralph Woessner, et al. · Clinical Drug Investigation · 16
Systemic pharmacokinetics of indacaterol, an inhaled once-daily long-acting ?2-agonist, in different ethnic populations
2012 · Soichiro Matsushima, Ivan Matthews, et al. · International Journal of Clinical Pharmacology and Therapeutics · 8
Integrated Quantitation of Biotherapeutic Drug–Target Binding, Biomarkers, and Clinical Response to Support Rational Dose Regimen Selection
2015 · Philip J. Lowe, Anne Kümmel, et al. · Pharmaceutical Sciences Encyclopedia · 4
Pharmacological and clinical profile of indacaterol maleate (Onbrez^|^reg;), an inhaled long-acting ^|^beta;2-adrenoceptor agonist
2012 · Kazuhiko Suzuki, Masahiko Uchiyama, et al. · Folia Pharmacologica Japonica
PDF
Construction of the in vitro transporter experimental systems for prediction of the dexification of drugs in human liver : Utilization of human cryopreserved hepatocytes and double transfectants
2006 · Kazuya Maeda, Masaru Hirano, et al. · Alternatives to animal testing and experimentation : AATEX
乳房腫瘍耐性蛋白質(bcrp)はピタバスタチンの胆汁分泌に重要な役割を果す
2005 · Masaru Hirano, Kazuya Maeda, et al.
Works count: 15
Citation count: 960
H-index: 10
I10-index: 10
Year
Topic
Type